Literature DB >> 24503977

Has catechol-O-methyltransferase genotype (Val158Met) an influence on endocrine, sympathetic nervous and humoral immune systems in women with fibromyalgia syndrome?

César Fernández-de-las-Peñas1, Cecilia Peñacoba-Puente, Margarita Cigarán-Méndez, Lourdes Díaz-Rodríguez, Belén Rubio-Ruiz, Manuel Arroyo-Morales.   

Abstract

OBJECTIVE: Stress can play an important role in etiology of fibromyalgia syndrome (FMS) by activating the hypothalamic-pituitary-adrenal (HPA) axis, the sympathetic nervous system (SNS), and altering the immune system. The current study examined the influence of catechol-O-methyltransferase (COMT) Val158Met genotypes on salivary markers of HPA axis (cortisol), SNS (α-amylase), and immune (IgA) systems in women with FMS.
METHODS: Seventy-six women with FMS diagnosed according to the American College of Rheumatology criteria participated in the study. Salivary cortisol, α-amylase activity, salivary flow rate, and IgA concentration were collected from nonstimulated saliva. A numerical pain rate scale (0 to 10) was used to assess the intensity of pain, whereas functional ability was determined using the Fibromyalgia Impact Questionnaire (FIQ). After amplifying Val158Met polymorphisms by polymerase chain reaction, 3 COMT genotypes were considered: Val/Val, Val/Met, and Met/Met.
RESULTS: Women with FMS with the Met/Met genotype reported higher α-amylase activity, lower salivary flow rate, and lower IgA concentration than those women with FMS carrying the Val/Met (P<0.05) or Val/Val (P<0.01) genotypes. No difference in cortisol concentration (P>0.70) was found. These results were not associated with the intensity of pain, disability, and medication intake.
CONCLUSIONS: The results suggest that women with FMS with the Met/Met genotype exhibit greater disturbed activity of the SNS and humoral immune system. These results provide initial evidence of a link between Val158Met polymorphism and dysfunctions in the SNS and humoral immune system in women with FMS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24503977     DOI: 10.1097/AJP.0b013e3182928da0

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  5 in total

1.  Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score: a meta-analysis.

Authors:  Young Ho Lee; Jae-Hoon Kim; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2014-06-21       Impact factor: 2.631

Review 2.  2-methoxyestradiol and disorders of female reproductive tissues.

Authors:  Mauricio P Pinto; Rodolfo A Medina; Gareth I Owen
Journal:  Horm Cancer       Date:  2014-04-25       Impact factor: 3.869

3.  Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome.

Authors:  Madlen Löbel; Agnes Anna Mooslechner; Sandra Bauer; Sabrina Günther; Anne Letsch; Leif G Hanitsch; Patricia Grabowski; Christian Meisel; Hans-Dieter Volk; Carmen Scheibenbogen
Journal:  J Transl Med       Date:  2015-08-14       Impact factor: 5.531

4.  Preliminary evidence for conserved transcriptional response to adversity in adults with temporomandibular disorder.

Authors:  Christopher D King; Ian A Boggero; Grant S Schulert; Hannah M Pickerill; Steve Cole
Journal:  Pain Rep       Date:  2021-01-08

Review 5.  Application of Salivary Biomarkers in the Diagnosis of Fibromyalgia.

Authors:  Rebeca Illescas-Montes; Víctor J Costela-Ruiz; Lucía Melguizo-Rodríguez; Elvira De Luna-Bertos; Concepción Ruiz; Javier Ramos-Torrecillas
Journal:  Diagnostics (Basel)       Date:  2021-01-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.